[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Tetanus Vaccine (Adsorbed) Market Growth 2024-2030

July 2024 | 120 pages | ID: G29B38203D01EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Tetanus Vaccine (Adsorbed) is a preparation of Tetanus formol toxoid adsorbed on aluminium phosphate gel. Thiomersal is used as a preservative. The potency is not less than 40 International Units per single human dose.

The global Tetanus Vaccine (Adsorbed) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Tetanus Vaccine (Adsorbed) Industry Forecast” looks at past sales and reviews total world Tetanus Vaccine (Adsorbed) sales in 2023, providing a comprehensive analysis by region and market sector of projected Tetanus Vaccine (Adsorbed) sales for 2024 through 2030. With Tetanus Vaccine (Adsorbed) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tetanus Vaccine (Adsorbed) industry.

This Insight Report provides a comprehensive analysis of the global Tetanus Vaccine (Adsorbed) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tetanus Vaccine (Adsorbed) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tetanus Vaccine (Adsorbed) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tetanus Vaccine (Adsorbed) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tetanus Vaccine (Adsorbed).

United States market for Tetanus Vaccine (Adsorbed) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Tetanus Vaccine (Adsorbed) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Tetanus Vaccine (Adsorbed) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Tetanus Vaccine (Adsorbed) players cover Sanofi Pasteur, GSK, Bio Farma, Serum Institute of India, Panacea Biotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Tetanus Vaccine (Adsorbed) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Tetanus Vaccine
  • Combined Vaccine
Segmentation by Application:
  • Children
  • Teenager
  • Adult
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Sanofi Pasteur
  • GSK
  • Bio Farma
  • Serum Institute of India
  • Panacea Biotec
  • Mitsubishi Tanabe Pharma
  • KM Biologics
  • MassBiologics
  • Chengdu Oulin Biological
  • Hualan Biological Bacterin
  • Wuhan Biological Products
Key Questions Addressed in this Report

What is the 10-year outlook for the global Tetanus Vaccine (Adsorbed) market?

What factors are driving Tetanus Vaccine (Adsorbed) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tetanus Vaccine (Adsorbed) market opportunities vary by end market size?

How does Tetanus Vaccine (Adsorbed) break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tetanus Vaccine (Adsorbed) Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Tetanus Vaccine (Adsorbed) by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Tetanus Vaccine (Adsorbed) by Country/Region, 2019, 2023 & 2030
2.2 Tetanus Vaccine (Adsorbed) Segment by Type
  2.2.1 Tetanus Vaccine
  2.2.2 Combined Vaccine
2.3 Tetanus Vaccine (Adsorbed) Sales by Type
  2.3.1 Global Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2019-2024)
  2.3.2 Global Tetanus Vaccine (Adsorbed) Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Tetanus Vaccine (Adsorbed) Sale Price by Type (2019-2024)
2.4 Tetanus Vaccine (Adsorbed) Segment by Application
  2.4.1 Children
  2.4.2 Teenager
  2.4.3 Adult
2.5 Tetanus Vaccine (Adsorbed) Sales by Application
  2.5.1 Global Tetanus Vaccine (Adsorbed) Sale Market Share by Application (2019-2024)
  2.5.2 Global Tetanus Vaccine (Adsorbed) Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Tetanus Vaccine (Adsorbed) Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Tetanus Vaccine (Adsorbed) Breakdown Data by Company
  3.1.1 Global Tetanus Vaccine (Adsorbed) Annual Sales by Company (2019-2024)
  3.1.2 Global Tetanus Vaccine (Adsorbed) Sales Market Share by Company (2019-2024)
3.2 Global Tetanus Vaccine (Adsorbed) Annual Revenue by Company (2019-2024)
  3.2.1 Global Tetanus Vaccine (Adsorbed) Revenue by Company (2019-2024)
  3.2.2 Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Company (2019-2024)
3.3 Global Tetanus Vaccine (Adsorbed) Sale Price by Company
3.4 Key Manufacturers Tetanus Vaccine (Adsorbed) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Tetanus Vaccine (Adsorbed) Product Location Distribution
  3.4.2 Players Tetanus Vaccine (Adsorbed) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TETANUS VACCINE (ADSORBED) BY GEOGRAPHIC REGION

4.1 World Historic Tetanus Vaccine (Adsorbed) Market Size by Geographic Region (2019-2024)
  4.1.1 Global Tetanus Vaccine (Adsorbed) Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Tetanus Vaccine (Adsorbed) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Tetanus Vaccine (Adsorbed) Market Size by Country/Region (2019-2024)
  4.2.1 Global Tetanus Vaccine (Adsorbed) Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Tetanus Vaccine (Adsorbed) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tetanus Vaccine (Adsorbed) Sales Growth
4.4 APAC Tetanus Vaccine (Adsorbed) Sales Growth
4.5 Europe Tetanus Vaccine (Adsorbed) Sales Growth
4.6 Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Growth

5 AMERICAS

5.1 Americas Tetanus Vaccine (Adsorbed) Sales by Country
  5.1.1 Americas Tetanus Vaccine (Adsorbed) Sales by Country (2019-2024)
  5.1.2 Americas Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2024)
5.2 Americas Tetanus Vaccine (Adsorbed) Sales by Type (2019-2024)
5.3 Americas Tetanus Vaccine (Adsorbed) Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tetanus Vaccine (Adsorbed) Sales by Region
  6.1.1 APAC Tetanus Vaccine (Adsorbed) Sales by Region (2019-2024)
  6.1.2 APAC Tetanus Vaccine (Adsorbed) Revenue by Region (2019-2024)
6.2 APAC Tetanus Vaccine (Adsorbed) Sales by Type (2019-2024)
6.3 APAC Tetanus Vaccine (Adsorbed) Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Tetanus Vaccine (Adsorbed) by Country
  7.1.1 Europe Tetanus Vaccine (Adsorbed) Sales by Country (2019-2024)
  7.1.2 Europe Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2024)
7.2 Europe Tetanus Vaccine (Adsorbed) Sales by Type (2019-2024)
7.3 Europe Tetanus Vaccine (Adsorbed) Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tetanus Vaccine (Adsorbed) by Country
  8.1.1 Middle East & Africa Tetanus Vaccine (Adsorbed) Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2024)
8.2 Middle East & Africa Tetanus Vaccine (Adsorbed) Sales by Type (2019-2024)
8.3 Middle East & Africa Tetanus Vaccine (Adsorbed) Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tetanus Vaccine (Adsorbed)
10.3 Manufacturing Process Analysis of Tetanus Vaccine (Adsorbed)
10.4 Industry Chain Structure of Tetanus Vaccine (Adsorbed)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Tetanus Vaccine (Adsorbed) Distributors
11.3 Tetanus Vaccine (Adsorbed) Customer

12 WORLD FORECAST REVIEW FOR TETANUS VACCINE (ADSORBED) BY GEOGRAPHIC REGION

12.1 Global Tetanus Vaccine (Adsorbed) Market Size Forecast by Region
  12.1.1 Global Tetanus Vaccine (Adsorbed) Forecast by Region (2025-2030)
  12.1.2 Global Tetanus Vaccine (Adsorbed) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Tetanus Vaccine (Adsorbed) Forecast by Type (2025-2030)
12.7 Global Tetanus Vaccine (Adsorbed) Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi Pasteur
  13.1.1 Sanofi Pasteur Company Information
  13.1.2 Sanofi Pasteur Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.1.3 Sanofi Pasteur Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Sanofi Pasteur Main Business Overview
  13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
  13.2.1 GSK Company Information
  13.2.2 GSK Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.2.3 GSK Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 GSK Main Business Overview
  13.2.5 GSK Latest Developments
13.3 Bio Farma
  13.3.1 Bio Farma Company Information
  13.3.2 Bio Farma Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.3.3 Bio Farma Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Bio Farma Main Business Overview
  13.3.5 Bio Farma Latest Developments
13.4 Serum Institute of India
  13.4.1 Serum Institute of India Company Information
  13.4.2 Serum Institute of India Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.4.3 Serum Institute of India Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Serum Institute of India Main Business Overview
  13.4.5 Serum Institute of India Latest Developments
13.5 Panacea Biotec
  13.5.1 Panacea Biotec Company Information
  13.5.2 Panacea Biotec Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.5.3 Panacea Biotec Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Panacea Biotec Main Business Overview
  13.5.5 Panacea Biotec Latest Developments
13.6 Mitsubishi Tanabe Pharma
  13.6.1 Mitsubishi Tanabe Pharma Company Information
  13.6.2 Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.6.3 Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Mitsubishi Tanabe Pharma Main Business Overview
  13.6.5 Mitsubishi Tanabe Pharma Latest Developments
13.7 KM Biologics
  13.7.1 KM Biologics Company Information
  13.7.2 KM Biologics Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.7.3 KM Biologics Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 KM Biologics Main Business Overview
  13.7.5 KM Biologics Latest Developments
13.8 MassBiologics
  13.8.1 MassBiologics Company Information
  13.8.2 MassBiologics Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.8.3 MassBiologics Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 MassBiologics Main Business Overview
  13.8.5 MassBiologics Latest Developments
13.9 Chengdu Oulin Biological
  13.9.1 Chengdu Oulin Biological Company Information
  13.9.2 Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.9.3 Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Chengdu Oulin Biological Main Business Overview
  13.9.5 Chengdu Oulin Biological Latest Developments
13.10 Hualan Biological Bacterin
  13.10.1 Hualan Biological Bacterin Company Information
  13.10.2 Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.10.3 Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Hualan Biological Bacterin Main Business Overview
  13.10.5 Hualan Biological Bacterin Latest Developments
13.11 Wuhan Biological Products
  13.11.1 Wuhan Biological Products Company Information
  13.11.2 Wuhan Biological Products Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
  13.11.3 Wuhan Biological Products Tetanus Vaccine (Adsorbed) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Wuhan Biological Products Main Business Overview
  13.11.5 Wuhan Biological Products Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Tetanus Vaccine (Adsorbed) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Tetanus Vaccine (Adsorbed) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Tetanus Vaccine
Table 4. Major Players of Combined Vaccine
Table 5. Global Tetanus Vaccine (Adsorbed) Sales by Type (2019-2024) & (K Dose)
Table 6. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2019-2024)
Table 7. Global Tetanus Vaccine (Adsorbed) Revenue by Type (2019-2024) & ($ million)
Table 8. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Type (2019-2024)
Table 9. Global Tetanus Vaccine (Adsorbed) Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global Tetanus Vaccine (Adsorbed) Sale by Application (2019-2024) & (K Dose)
Table 11. Global Tetanus Vaccine (Adsorbed) Sale Market Share by Application (2019-2024)
Table 12. Global Tetanus Vaccine (Adsorbed) Revenue by Application (2019-2024) & ($ million)
Table 13. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Application (2019-2024)
Table 14. Global Tetanus Vaccine (Adsorbed) Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global Tetanus Vaccine (Adsorbed) Sales by Company (2019-2024) & (K Dose)
Table 16. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Company (2019-2024)
Table 17. Global Tetanus Vaccine (Adsorbed) Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Company (2019-2024)
Table 19. Global Tetanus Vaccine (Adsorbed) Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers Tetanus Vaccine (Adsorbed) Producing Area Distribution and Sales Area
Table 21. Players Tetanus Vaccine (Adsorbed) Products Offered
Table 22. Tetanus Vaccine (Adsorbed) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Tetanus Vaccine (Adsorbed) Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global Tetanus Vaccine (Adsorbed) Sales Market Share Geographic Region (2019-2024)
Table 27. Global Tetanus Vaccine (Adsorbed) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Tetanus Vaccine (Adsorbed) Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Country/Region (2019-2024)
Table 31. Global Tetanus Vaccine (Adsorbed) Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Tetanus Vaccine (Adsorbed) Sales by Country (2019-2024) & (K Dose)
Table 34. Americas Tetanus Vaccine (Adsorbed) Sales Market Share by Country (2019-2024)
Table 35. Americas Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Tetanus Vaccine (Adsorbed) Sales by Type (2019-2024) & (K Dose)
Table 37. Americas Tetanus Vaccine (Adsorbed) Sales by Application (2019-2024) & (K Dose)
Table 38. APAC Tetanus Vaccine (Adsorbed) Sales by Region (2019-2024) & (K Dose)
Table 39. APAC Tetanus Vaccine (Adsorbed) Sales Market Share by Region (2019-2024)
Table 40. APAC Tetanus Vaccine (Adsorbed) Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Tetanus Vaccine (Adsorbed) Sales by Type (2019-2024) & (K Dose)
Table 42. APAC Tetanus Vaccine (Adsorbed) Sales by Application (2019-2024) & (K Dose)
Table 43. Europe Tetanus Vaccine (Adsorbed) Sales by Country (2019-2024) & (K Dose)
Table 44. Europe Tetanus Vaccine (Adsorbed) Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Tetanus Vaccine (Adsorbed) Sales by Type (2019-2024) & (K Dose)
Table 46. Europe Tetanus Vaccine (Adsorbed) Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Tetanus Vaccine (Adsorbed)
Table 52. Key Market Challenges & Risks of Tetanus Vaccine (Adsorbed)
Table 53. Key Industry Trends of Tetanus Vaccine (Adsorbed)
Table 54. Tetanus Vaccine (Adsorbed) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Tetanus Vaccine (Adsorbed) Distributors List
Table 57. Tetanus Vaccine (Adsorbed) Customer List
Table 58. Global Tetanus Vaccine (Adsorbed) Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global Tetanus Vaccine (Adsorbed) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Tetanus Vaccine (Adsorbed) Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas Tetanus Vaccine (Adsorbed) Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Tetanus Vaccine (Adsorbed) Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC Tetanus Vaccine (Adsorbed) Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Tetanus Vaccine (Adsorbed) Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe Tetanus Vaccine (Adsorbed) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa Tetanus Vaccine (Adsorbed) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Tetanus Vaccine (Adsorbed) Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global Tetanus Vaccine (Adsorbed) Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Tetanus Vaccine (Adsorbed) Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global Tetanus Vaccine (Adsorbed) Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Sanofi Pasteur Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pasteur Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 74. Sanofi Pasteur Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Sanofi Pasteur Main Business
Table 76. Sanofi Pasteur Latest Developments
Table 77. GSK Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 79. GSK Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Bio Farma Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 83. Bio Farma Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 84. Bio Farma Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Bio Farma Main Business
Table 86. Bio Farma Latest Developments
Table 87. Serum Institute of India Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 88. Serum Institute of India Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 89. Serum Institute of India Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Serum Institute of India Main Business
Table 91. Serum Institute of India Latest Developments
Table 92. Panacea Biotec Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 93. Panacea Biotec Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 94. Panacea Biotec Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Panacea Biotec Main Business
Table 96. Panacea Biotec Latest Developments
Table 97. Mitsubishi Tanabe Pharma Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 98. Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 99. Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Mitsubishi Tanabe Pharma Main Business
Table 101. Mitsubishi Tanabe Pharma Latest Developments
Table 102. KM Biologics Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 103. KM Biologics Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 104. KM Biologics Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. KM Biologics Main Business
Table 106. KM Biologics Latest Developments
Table 107. MassBiologics Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 108. MassBiologics Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 109. MassBiologics Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. MassBiologics Main Business
Table 111. MassBiologics Latest Developments
Table 112. Chengdu Oulin Biological Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 113. Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 114. Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 115. Chengdu Oulin Biological Main Business
Table 116. Chengdu Oulin Biological Latest Developments
Table 117. Hualan Biological Bacterin Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 118. Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 119. Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 120. Hualan Biological Bacterin Main Business
Table 121. Hualan Biological Bacterin Latest Developments
Table 122. Wuhan Biological Products Basic Information, Tetanus Vaccine (Adsorbed) Manufacturing Base, Sales Area and Its Competitors
Table 123. Wuhan Biological Products Tetanus Vaccine (Adsorbed) Product Portfolios and Specifications
Table 124. Wuhan Biological Products Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 125. Wuhan Biological Products Main Business
Table 126. Wuhan Biological Products Latest Developments



LIST OF FIGURES

Figure 1. Picture of Tetanus Vaccine (Adsorbed)
Figure 2. Tetanus Vaccine (Adsorbed) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tetanus Vaccine (Adsorbed) Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Tetanus Vaccine (Adsorbed) Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Tetanus Vaccine (Adsorbed) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Tetanus Vaccine (Adsorbed) Sales Market Share by Country/Region (2023)
Figure 10. Tetanus Vaccine (Adsorbed) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Tetanus Vaccine
Figure 12. Product Picture of Combined Vaccine
Figure 13. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Type in 2023
Figure 14. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Type (2019-2024)
Figure 15. Tetanus Vaccine (Adsorbed) Consumed in Children
Figure 16. Global Tetanus Vaccine (Adsorbed) Market: Children (2019-2024) & (K Dose)
Figure 17. Tetanus Vaccine (Adsorbed) Consumed in Teenager
Figure 18. Global Tetanus Vaccine (Adsorbed) Market: Teenager (2019-2024) & (K Dose)
Figure 19. Tetanus Vaccine (Adsorbed) Consumed in Adult
Figure 20. Global Tetanus Vaccine (Adsorbed) Market: Adult (2019-2024) & (K Dose)
Figure 21. Global Tetanus Vaccine (Adsorbed) Sale Market Share by Application (2023)
Figure 22. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Application in 2023
Figure 23. Tetanus Vaccine (Adsorbed) Sales by Company in 2023 (K Dose)
Figure 24. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Company in 2023
Figure 25. Tetanus Vaccine (Adsorbed) Revenue by Company in 2023 ($ millions)
Figure 26. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Company in 2023
Figure 27. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Tetanus Vaccine (Adsorbed) Sales 2019-2024 (K Dose)
Figure 30. Americas Tetanus Vaccine (Adsorbed) Revenue 2019-2024 ($ millions)
Figure 31. APAC Tetanus Vaccine (Adsorbed) Sales 2019-2024 (K Dose)
Figure 32. APAC Tetanus Vaccine (Adsorbed) Revenue 2019-2024 ($ millions)
Figure 33. Europe Tetanus Vaccine (Adsorbed) Sales 2019-2024 (K Dose)
Figure 34. Europe Tetanus Vaccine (Adsorbed) Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales 2019-2024 (K Dose)
Figure 36. Middle East & Africa Tetanus Vaccine (Adsorbed) Revenue 2019-2024 ($ millions)
Figure 37. Americas Tetanus Vaccine (Adsorbed) Sales Market Share by Country in 2023
Figure 38. Americas Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2019-2024)
Figure 39. Americas Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2019-2024)
Figure 40. Americas Tetanus Vaccine (Adsorbed) Sales Market Share by Application (2019-2024)
Figure 41. United States Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Tetanus Vaccine (Adsorbed) Sales Market Share by Region in 2023
Figure 46. APAC Tetanus Vaccine (Adsorbed) Revenue Market Share by Region (2019-2024)
Figure 47. APAC Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2019-2024)
Figure 48. APAC Tetanus Vaccine (Adsorbed) Sales Market Share by Application (2019-2024)
Figure 49. China Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 53. India Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Tetanus Vaccine (Adsorbed) Sales Market Share by Country in 2023
Figure 57. Europe Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2019-2024)
Figure 58. Europe Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2019-2024)
Figure 59. Europe Tetanus Vaccine (Adsorbed) Sales Market Share by Application (2019-2024)
Figure 60. Germany Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 61. France Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Market Share by Application (2019-2024)
Figure 68. Egypt Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Tetanus Vaccine (Adsorbed) Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Tetanus Vaccine (Adsorbed) in 2023
Figure 74. Manufacturing Process Analysis of Tetanus Vaccine (Adsorbed)
Figure 75. Industry Chain Structure of Tetanus Vaccine (Adsorbed)
Figure 76. Channels of Distribution
Figure 77. Global Tetanus Vaccine (Adsorbed) Sales Market Forecast by Region (2025-2030)
Figure 78. Global Tetanus Vaccine (Adsorbed) Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Tetanus Vaccine (Adsorbed) Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Tetanus Vaccine (Adsorbed) Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Tetanus Vaccine (Adsorbed) Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Tetanus Vaccine (Adsorbed) Revenue Market Share Forecast by Application (2025-2030)


More Publications